Tom 14, Nr 2 (2017)
List do Redakcji
Opublikowany online: 2017-08-24

dostęp otwarty

Wyświetlenia strony 349
Wyświetlenia/pobrania artykułu 2056
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Zdalne monitorowania wysokoenergetycznych urządzeń wszczepialnych u chorych z niewydolnością serca; RESULT — pierwsze polskie badanie randomizowane

Mateusz Tajstra1, Marcin Wilczek2, Mariusz Gąsior1, Lech Poloński1
Choroby Serca i Naczyń 2017;14(2):111-113.

Streszczenie

Brak

Referencje

  1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007; 93(9): 1137–1146.
  2. Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289(2): 194–202.
  3. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J. 2004; 25(18): 1614–1619.
  4. Ceia F, Fonseca C, Mota T, et al. EPICA Investigators. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail. 2002; 4(4): 531–539.
  5. Slotwiner D, Varma N, Akar JG, et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm. 2015; 12(7): e69–100.
  6. Varma N, Michalski J, Epstein AE, et al. TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010; 122(4): 325–332.
  7. Hindricks G, Taborsky M, Glikson M, et al. IN-TIME study group. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014; 384(9943): 583–590.
  8. Boriani G, Da Costa A, Quesada A, et al. MORE-CARE Study Investigators. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail. 2017; 19(3): 416–425.
  9. Morgan JM, Kitt S, Gill J, et al. Remote management of heart failure using implantable electronic devices. Eur Heart J. 2017 [Epub ahead of print].
  10. Parthiban N, Esterman A, Mahajan R, et al. Remote 0onitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. J Am Coll Cardiol. 2015; 65(24): 2591–2600.
  11. Klersy C, Boriani G, De Silvestri A, et al. Health Economics Committee of the European Heart Rhythm Association. Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized controlled trials in patients with heart failure. Eur J Heart Fail. 2016; 18(2): 195–204.
  12. Kurek A, Tajstra M, Gadula-Gacek E, et al. Impact of remote monitoring on long-term prognosis in heart failure patients in a real-world cohort: results from all-comers COMMIT-HF Trial. J Cardiovasc Electrophysiol. 2017; 28(4): 425–431.
  13. Buchta P, Tajstra M, Kurek A, et al. The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up. Kardiol Pol. 2017; 75(6): 573–580.
  14. Tajstra M, Sokal A, Gwóźdź A, et al. REmote SUpervision to Decrease HospitaLization RaTe. Unified and integrated platform for data collected from devices manufactured by different companies: Design and rationale of the RESULT study. Ann Noninvasive Electrocardiol. 2017; 22(4).